| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_500cb1713f799f6d75f2631afcc4a011 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 |
| filingDate |
2012-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_254b284639acb69bff8f697c0bbbb3f3 |
| publicationDate |
2016-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-617553-A |
| titleOfInvention |
Compound dual-release capsule formulation comprised of bromodihydroartemisinin and a fe2+ agent |
| abstract |
Provided is a dual-release capsule formulation comprising bromodihydroartemisinin and an Fe2+ agent as the active pharmaceutical ingredients. The formulation comprises an enteric-coated pellet comprising bromodihydroartemisinin and an immediate release pellet comprising an Fe2+ agent encapsulated in a gastric soluble capsule. Preferred Fe2+ agents include ferrous sulphate, ferrous lactate and ferrous succinate. Bromodihydroartemisinin is an anti-cancer agent. |
| priorityDate |
2011-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |